Back to All Events

Alcohol, Opiates, and other Drugs: Identifying the Child Affected by Prenatal Substance Exposure

Presented by Ira J. Chasnoff, MD

This session will review the core diagnostic elements for identifying children affected by prenatal substance exposure and describe a framework for recognizing the behavior and developmental difficulties this population of children may exhibit.

Learning objectives

At the completion of this session, participants will be able to:

  1. Name two changes in the structure and function of the developing fetal brain due to prenatal substance exposure.

  2. Identify three neurodevelopmental domains that frequently are affected by prenatal substance exposure.

  3. Discuss a conceptual framework for assessing behavior for children and youth affected by prenatal substance exposure.

Previous
Previous
June 18

Stigma and Bias in the Healthcare System: What can we do about it?

Next
Next
November 12

Sensory Processing: Strategies for the Home and Clinic